Do Not Do Recommendation
Do not withhold anticoagulation solely because the person is at risk of having a fall.
Do Not Do Recommendation Details
- Do not withhold anticoagulation solely because the person is at risk of having a fall.
Source guidance details
- Atrial fibrillation: the management of atrial fibrillation (CG180)
- Published date:
- June 2014
- Paragraph number:
- Page number:
View all NICE do not do from this Guidance
- Do not routinely perform TTE (transthoracic echocardiography) solely for the purpose of further stroke risk stratification in people with atrial fibrillation for whom the need to initiate anticoagulation therapy has already been agreed on appropriate clinical criteria (see section 1.4 Assessment of stroke and bleeding risks and section 1.5 Interventions to prevent stroke).
- Do not offer stroke prevention therapy to people aged under 65 years with atrial fibrillation and no risk factors other than their sex (that is, very low risk of stroke equating to a CHA2DS2-VASc score of 0 for men or 1 for women).
- Do not offer aspirin monotherapy solely for stroke prevention to people with atrial fibrillation.
- Do not offer LAAO (left atrial appendage occlusion) as an alternative to anticoagulation unless anticoagulation is contraindicated or not tolerated.
- Do not offer amiodarone for long-term rate control.
- Do not offer class 1c antiarrhythmic drugs such as flecainide or propafenone to people with known ischaemic or structural heart disease.
- Do not offer magnesium or a calcium-channel blocker for pharmacological cardioversion.
- In people undergoing cardiothoracic surgery do not offer digoxin.